Healthways (NASDAQ:HWAY) was downgraded by investment analysts at William Blair to a “market perform” rating in a note issued to investors on Tuesday, Analyst Ratings.Net reports.
Other equities research analysts have also recently issued reports about the stock. Analysts at Thomson Reuters/Verus upgraded shares of Healthways (NASDAQ:HWAY) from a “hold” rating to a “buy” rating in a research note to investors on Monday. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Healthways (NASDAQ:HWAY) in a research note to investors on Monday. They now have a $19.00 price target on the stock. Finally, analysts at Citigroup Inc. initiated coverage on shares of Healthways (NASDAQ:HWAY) in a research note to investors on Thursday, July 25th. They set an “equal weight” rating on the stock.
One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $16.17.
Healthways (NASDAQ:HWAY) traded up 0.39% on Tuesday, hitting $18.00. 350,674 shares of the company’s stock traded hands. Healthways has a one year low of $8.58 and a one year high of $22.20. The stock has a 50-day moving average of $19.03 and a 200-day moving average of $15.4. The company has a market cap of $619.2 million and a P/E ratio of 1054.71.
Healthways (NASDAQ:HWAY) last announced its earnings results on Wednesday, July 24th. The company reported ($0.03) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.05) by $0.02. The company had revenue of $162.27 million for the quarter, compared to the consensus estimate of $170.30 million. During the same quarter in the prior year, the company posted $0.15 earnings per share. The company’s quarterly revenue was down 4.7% on a year-over-year basis. Analysts expect that Healthways will post $0.22 EPS for the current fiscal year.
Healthways, Inc provides solutions to help people improve physical, emotional and social well-being. The Company provides specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.